Bullous pemphigoid (BP) is an autoimmune blistering disease which carries a significant
mortality and morbidity. While historically BP has been characterized as an IgG driven …

Bullous pemphigoid (BP) is an autoimmune blistering disease characterized by
autoantibodies targeting cellular adhesion molecules. While IgE autoantibodies are …

Eosinophils are typically associated with unique inflammatory settings, including allergic
inflammation and helminth infections. However, new information suggests that eosinophils …

Background Bullous pemphigoid (BP) is an autoimmune bullous disease of the skin
characterized by subepidermal blister formation due to tissue‐bound and circulating …

Bullous pemphigoid (BP) is an autoimmune blistering disease mediated by autoantibodies
targeting BP180 (type XVII collagen). Patient sera and tissues typically have IgG and IgE …

Bullous Pemphigoid (BP) is an inflammatory rare autoimmune bullous dermatosis, which
outcome cannot be predicted through clinical investigations. Eosinophils are the main …

Background Peripheral eosinophilia has been reported in 50–60% of patients with bullous
pemphigoid (BP) and correlated positively with disease severity. Objectives To establish an …

Background Bullous pemphigoid (BP) often provokes blood and tissue eosinophilia, which
suggests that some chemoattractants modulate the eosinophil infiltration in BP. Eotaxin, a …

Background Bullous pemphigoid (BP) is an autoimmune disease characterized by tense
blisters that are usually preceded by urticarial eruptions. Affected patients exhibit IgG and/or …

Bullous pemphigoid (BP), a cutaneous autoimmune blistering disease, has provided a
useful model to elucidate a role for IgE in autoimmunity. IgE antibodies specific for the …